Market Exclusive

Analyst Upgrades – Aratana Therapeutics (NASDAQ:PETX) (NASDAQ:PETX) Stock Gets Upgraded By Stifel Nicolaus from Hold to Buy

Analyst Ratings For Aratana Therapeutics (NASDAQ:PETX) (NASDAQ:PETX)

Today, Aratana Therapeutics (NASDAQ:PETX) (NASDAQ:PETX) stock received an upgrade by Stifel Nicolaus from Hold to Buy with a price target of $8.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Aratana Therapeutics (NASDAQ:PETX) (NASDAQ:PETX)
Aratana Therapeutics (NASDAQ:PETX) (NASDAQ:PETX) has insider ownership of 5.20% and institutional ownership of 66.65%.

Recent Trading Activity for Aratana Therapeutics (NASDAQ:PETX) (NASDAQ:PETX)
Shares of Aratana Therapeutics (NASDAQ:PETX) closed the previous trading session at 4.10 up +0.23 6.02% with shares trading hands.

Exit mobile version